News

Ocular Therapeutix Announces Conference for 2024 Financial Results

Ocular Therapeutix Announces Conference for 2024 Financial Results

Ocular Therapeutix Announces Upcoming Conference Call

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a leading biopharmaceutical innovator, is preparing to share its latest financial progress and business advancements during an important conference call. This event is scheduled for a morning in early March, where the management team will discuss crucial updates surrounding their operations as well as the financial results of the fourth quarter and the full year.

Details of the Conference Call

Participants can expect the call to kick off at 8:00 AM ET, with involvement from key executives of the company. This conference promises to be a comprehensive overview of Ocular Therapeutix's significant steps toward advancing ocular therapies, particularly focusing on its innovative product pipeline.

Insights on Ocular Therapeutix's Products

Ocular Therapeutix is dedicated to enhancing the retina experience, specifically with its flagship product AXPAXLI™. This intravitreal hydrogel candidate is currently making headway in Phase 3 clinical trials, targeting wet age-related macular degeneration (wet AMD). This advancement is anticipated to create new treatment options for patients battling this prevalent condition.

Technology Driving Innovation

At the core of Ocular’s breakthroughs is the ELUTYX™ proprietary formulation technology. This technology not only underpins AXPAXLI but is also integral to their marketed product, DEXTENZA, an FDA-approved treatment designed to alleviate ocular inflammation and pain. Ocular continues to explore how this bioresorbable hydrogel could reshape treatment approaches in ophthalmology.

Expanding Clinical Trials and Research

Beyond AXPAXLI, Ocular Therapeutix is also progressing with PAXTRAVA™. This promising candidate, currently in a Phase 2 clinical trial, aims to provide effective treatment for open-angle glaucoma and ocular hypertension through its unique travoprost intracameral injection formulation.

Engagement and Outreach

Ocular Therapeutix is engaging with the investment community through this upcoming call, showcasing their commitment to innovation and transparency. The company encourages investors and the public to follow their journey via their official website and social media platforms, remaining connected as they navigate the complexities of developing cutting-edge ophthalmic therapies.

Frequently Asked Questions

What is the purpose of the upcoming conference call?

The conference call is intended to provide updates on Ocular Therapeutix's business progress and to discuss financial results for the fourth quarter and full year.

When is the conference call scheduled?

The conference call is set for 8:00 AM ET on March 3, 2025.

What products are currently in Ocular Therapeutix's pipeline?

Ocular Therapeutix’s pipeline includes AXPAXLI, which is in Phase 3 trials for wet AMD, and PAXTRAVA, currently in Phase 2 trials for glaucoma.

How can participants access the conference call?

Participants can dial designated numbers for the call and can also access the live and archived webcast via the company’s Investor Relations website.

Who can be contacted for more information?

For more details, investors and media are invited to reach out to Bill Slattery, Vice President of Investor Relations at Ocular Therapeutix.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Avive Partners with Cambridge Fire for Lifesaving Training

Updated Category News Views 4

Tapping into the Pulse: Avive & Cambridge Fire in Action No fooling around here—Avive Solutions is linking arms with the Cambridge Fire Department to put the city on a faster track to becoming a lifesaver haven. They're rolling out a free CPR and AED training right in the Smith Campus Center, Harvard Square. It's the kind of thing you love to see—getting the community...

Continue Reading
Paula's Choice Elevates Skincare Game with New Campaign

Updated Category News Views 4

Strategy Meets Skincare: Paula's Choice in the Spotlight Catch this: Paula's Choice just dropped a moisturizer, but it ain't just lotion. No, the Pro-Collagen Peptide Plumping Intensive Moisturizer is here with a punch. And they've got Hannah Waddingham, of 'Ted Lasso' fame, fronting a campaign that screams confidence. Now, that's a way to announce your move at the...

Continue Reading
Citrine Finalizes Sale of Illinois Senior Living Asset

Updated Category News Views 5

Citrine's Strategic Exit from River Glen Every now and then, you see a company pull off something that makes you nod and say, "That was smart." Citrine Investment Group's sale of River Glen of St. Charles fits that bill. For those keeping tabs, this wasn't some quick flip—Citrine worked on the rock for a good while before cashing in. They secured River Glen back in...

Continue Reading
Perk's U.S. Expansion: A Bold Move in Spend Control

Updated Category News Views 5

Perk Aims for U.S. Growth: Will It Pay Off? Amidst the cacophony of market chatter, Perk's announcement to bring its spend platform stateside is echoing louder than usual. This move is not just another step in its expansion but rather a leap considering the competition and market needs. In Europe, where they've already captured a chunk of the market with their Travel and...

Continue Reading
Inovonics Duress Card Enhances Safety for K-12 and Beyond

Updated Category News Views 5

A New Dawn for Safety in Schools and More It's about time we talk about something more substantial than just beefing up security cameras or tightening door locks. Real-world problems require nimble solutions, and that's where Status Solutions steps in with the Inovonics Duress Card. It's not just another gadget; it's a lightweight, wrist-mounted lifeline designed to say,...

Continue Reading
RxWellness Hits Inc. 5000—Four Straight Wins Impress

Updated Category News Views 6

RxWellness Spine & Health Continues to Impress Well, not many companies can boast about snagging a spot on the Inc. 5000 list four years in a row, but here we are with RxWellness Spine & Health doing just that. Sitting pretty at No. 1,230 nationally—and that's no small feat—these folks are making waves in the healthcare industry. Securing the No. 135 spot in...

Continue Reading
TWP & Commbi Unveil Exclusive Pony Clog Collaboration

Updated Category News Views 4

A Fusion of Fashion and Functionality Walk down the streets of New York or hustle your way through an airport without worrying about your footwear weighing you down. That's the promise coming from the fresh alliance between TWP and Commbi with their new Pony Clog Collaboration. A blend of high fashion and everyday utility, these clogs aren't just keeping up with the...

Continue Reading
NY Sheriffs' Court Battle: Immigration Policies Under Fire

Updated Category News Views 4

Sheriffs Clash with State Over Immigration Policies In a tense showdown reminiscent of an old-time standoff, 15 New York county sheriffs have drawn their battle lines against the state’s capricious maneuvers by pushing a federal court to hit the brakes on Albany’s newly minted immigration rule. The so-called “Local Cops, Local Crimes Act” is catching serious heat,...

Continue Reading
Alcott HR's Sales Strategy Gets a Boost with New Hire

Updated Category News Views 9

Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...

Continue Reading
Postal Connections Expands with New Hillsboro Opening

Updated Category News Views 6

Expanding Horizons in Hillsboro In the world of postal and office services, Annex Brands, Inc. is making headlines by launching yet another Postal Connections spot, this time planting its flag in the tech-centric town of Hillsboro, Oregon. Spearheaded by Jason Rautenkranz, this expansion is more than just another dot on a map—it's a strategic push into one of the...

Continue Reading

Top 5 Most Recently Viewed Articles

Leadership Transition at Plug Power: Jose Luis Crespo Takes Charge

Updated Category News Views 197

Significant Leadership Change at Plug Power Plug Power Inc. (NASDAQ: PLUG), a prominent player in hydrogen solutions, has announced an important leadership change by appointing Jose Luis Crespo as its new Chief Executive Officer. With a long history at Plug Power, Mr. Crespo will take over the helm as CEO effective when the company files its Annual Report, expected in...

Continue Reading
Investors Alert: Join the Applied Therapeutics Lawsuit Today

Updated Category News Views 175

Opportunity for Investors in Applied Therapeutics Case The Rosen Law Firm, a prominent name in investor rights, is urging individuals who purchased securities from Applied Therapeutics, Inc. (NASDAQ: APLT) to take notice. If you acquired securities during the defined Class Period, which spans from January 3, 2024, to December 2, 2024, mark your calendar for an important...

Continue Reading
PuroClean Responds to Increasing Flood Challenges Nationwide

Updated Category News Views 119

PuroClean Steps Up in the Face of Rising Flood Challenges The Paramedics of Property Damage shares vital flood recovery and prevention insights with national audiences. Preparation Tips for Flood Emergencies As flooding becomes a more frequent crisis across the U.S., PuroClean recognizes the need for communities to not only recover but also prepare for these overwhelming...

Continue Reading
American Tower Appoints New Leaders to Strengthen Operations

Updated Category News Views 677

American Tower Elevates Leadership for Streamlined Operations American Tower Corporation (NYSE: AMT) has announced pivotal changes in its leadership to bolster its operational efficiency and service offerings. These changes will significantly impact the company’s performance and strategic direction moving forward. Bud Noel Steps into COO Role Eugene (“Bud”) Noel,...

Continue Reading
Western Forest Products Plans Major Lumber Production Cuts

Updated Category News Views 91

Western Forest Products Implements Significant Production Reductions Western Forest Products Inc. (TSX: WEF) has recently made headlines with its announcement regarding lumber production reductions in its sawmills located in British Columbia. The company plans to cut its production by approximately 30 million board feet from October to December. This decision is part of a...

Continue Reading